NGVT · Ingevity Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.17B | $1.41B | $1.69B | $1.67B | $1.39B | $1.22B |
| Cost of Revenue | $706.10M | $951.70M | $1.22B | $1.10B | $878.70M | $750.60M |
| Gross Profit | $461.50M | $454.70M | $471.90M | $570.10M | $512.80M | $465.50M |
| R&D | $28.40M | $28.10M | $31.80M | $30.30M | $26.30M | $22.60M |
| SG&A | $171.20M | $166.70M | $183.70M | $198.80M | $179.30M | $149.40M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $106.40M | $108.30M | $122.80M | $108.80M | $109.90M | $100.20M |
| Operating Income | $418.70M | $369.00M | $396.80M | $452.60M | $422.20M | $397.90M |
| Interest Expense | $78.30M | $97.80M | $93.30M | $61.80M | $51.70M | $47.10M |
| Income Tax | $8.20M | ($105.30M) | ($4.70M) | $58.00M | $44.70M | $53.70M |
| Net Income | ($167.10M) | ($430.30M) | ($5.40M) | $211.60M | $118.10M | $181.40M |
| EPS - Basic | ($4.61) | ($11.85) | ($0.15) | $5.54 | $2.97 | $4.39 |
| EPS - Diluted | ($4.61) | ($11.85) | ($0.15) | $5.50 | $2.95 | $4.37 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $78.10M | $68.00M | $95.90M | $76.70M | $275.40M | $257.70M |
| Accounts Receivable | - | - | - | - | - | $148.00M |
| Inventory | $186.00M | $226.80M | $308.80M | $335.00M | $241.20M | $189.00M |
| Accounts Payable | $92.00M | $94.50M | $158.40M | $174.80M | $125.80M | $104.20M |
| Current Assets | $454.20M | $493.20M | $658.60M | $679.00M | $724.90M | $628.70M |
| Total Assets | $1.65B | $2.02B | $2.62B | $2.74B | $2.47B | $2.33B |
| Current Liabilities | $341.30M | $264.10M | $362.90M | $303.50M | $268.90M | $223.40M |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $1.62B | $1.83B | $1.99B | $2.04B | $1.80B | $1.69B |
| Stockholders' Equity | $29.70M | $195.20M | $631.40M | $698.30M | $673.80M | $642.10M |
| Retained Earnings | $404.90M | $572.00M | $1.00B | $1.01B | $796.10M | $678.00M |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $331.20M | $128.60M | $205.10M | $313.10M | $293.00M | $352.40M |
| Investing Cash Flow | ($57.50M) | ($79.50M) | ($77.30M) | ($553.90M) | ($140.60M) | ($110.60M) |
| Financing Cash Flow | ($252.20M) | ($70.20M) | ($99.90M) | $48.10M | ($133.10M) | ($50.20M) |
| CapEx | $57.70M | $77.60M | $109.80M | $142.50M | $103.80M | $82.10M |
| Free Cash Flow | $273.50M | $51.00M | $95.30M | $170.60M | $189.20M | $270.30M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 39.5% | 32.3% | 27.9% | 34.2% | 36.9% | 38.3% |
| Operating margin | 35.9% | 26.2% | 23.5% | 27.1% | 30.3% | 32.7% |
| EBITDA margin | 45.0% | 33.9% | 30.7% | 33.7% | 38.2% | 41.0% |
| Net margin | -14.3% | -30.6% | -0.3% | 12.7% | 8.5% | 14.9% |
| Free cash flow margin | 23.4% | 3.6% | 5.6% | 10.2% | 13.6% | 22.2% |
| FCF / Net income | -1.64 | -0.12 | -17.65 | 0.81 | 1.60 | 1.49 |
| R&D / Revenue | 2.4% | 2.0% | 1.9% | 1.8% | 1.9% | 1.9% |
| SG&A / Revenue | 14.7% | 11.9% | 10.9% | 11.9% | 12.9% | 12.3% |
| Effective tax rate | - | - | - | 21.5% | 27.5% | 22.8% |
| Return on assets | -10.1% | -21.3% | -0.2% | 7.7% | 4.8% | 7.8% |
| Return on equity | -562.6% | -220.4% | -0.9% | 30.3% | 17.5% | 28.3% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 1.33 | 1.87 | 1.81 | 2.24 | 2.70 | 2.81 |
| Quick ratio | 0.79 | 1.01 | 0.96 | 1.13 | 1.80 | 1.97 |
| Cash ratio | 0.23 | 0.26 | 0.26 | 0.25 | 1.02 | 1.15 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | 5.3x | 3.8x | 4.3x | 7.3x | 8.2x | 8.4x |
| Equity multiplier | 55.59 | 10.36 | 4.15 | 3.92 | 3.66 | 3.64 |
| Liabilities / Assets | 0.98 | 0.90 | 0.76 | 0.74 | 0.73 | 0.72 |
| Efficiency | ||||||
| Asset turnover | 0.71 | 0.70 | 0.65 | 0.61 | 0.56 | 0.52 |
| Inventory turnover | 3.80 | 4.20 | 3.95 | 3.28 | 3.64 | 3.97 |
| Days sales outstanding | - | - | - | - | - | 44d |
| Days inventory outstanding | 96d | 87d | 92d | 111d | 100d | 92d |
| Days payable outstanding | 48d | 36d | 47d | 58d | 52d | 51d |
| Cash conversion cycle | - | - | - | - | - | 86d |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | 72.2x | 7.6x | 2.7x | - | - | - |
| P / S | 1.8x | 1.1x | 1.0x | - | - | - |
| EV / EBITDA | 3.9x | 3.0x | 3.1x | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | -17.0% | -16.9% | 1.4% | 19.9% | 14.4% | -5.9% |
| Revenue CAGR (3y) | -11.2% | 0.4% | 11.6% | 8.9% | 15.3% | - |
| Revenue CAGR (5y) | -0.8% | 1.7% | 13.3% | - | - | - |
| Gross profit growth (YoY) | 1.5% | -3.6% | -17.2% | 11.2% | 10.2% | -3.4% |
| Operating income growth (YoY) | 13.5% | -7.0% | -12.3% | 7.2% | 6.1% | 0.3% |
| Net income growth (YoY) | 61.2% | -7868.5% | - | 79.2% | -34.9% | -1.3% |
| EPS growth (YoY) | 61.1% | -7800.0% | - | 86.4% | -32.5% | 0.5% |
| EPS CAGR (3y) | - | - | - | 8.1% | -9.4% | 13.7% |
| EPS CAGR (5y) | - | - | - | 13.1% | 28.9% | - |
| FCF growth (YoY) | 436.3% | -46.5% | -44.1% | -9.8% | -30.0% | 68.0% |
| FCF CAGR (5y) | 0.2% | -20.5% | -9.6% | 7.0% | 21.6% | - |
| Book value growth (YoY) | -84.8% | -69.1% | -9.6% | 3.6% | 4.9% | 21.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$1.17B totalPerformance Materials$606.90M · 52.0%
Performance Chemicals$400.50M · 34.3%
Advanced Polymer Technologies Segment$160.20M · 13.7%
Product / service
$400.50M totalPavement Technologies$302.60M · 75.6%
Road Markings$97.90M · 24.4%
Geographic
$1.91B totalNorth America$665.10M · 34.9%
US$585.00M · 30.7%
Asia Pacific$298.50M · 15.7%
EMEA$158.90M · 8.3%
CN$153.10M · 8.0%
South America$45.10M · 2.4%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
1.76
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
6/9
Neutral
- ✗Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✓Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Chemicals & Allied Products
Comparing Ingevity Corp against the 5 most active filers in the same SIC group.